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A B S T R A C T
Background: The implantation of stents to keep the ductus arteriosus patent in cyanotic congenital heart disease 
is an alternative to the modified Blalock-Taussig surgery (mBT) in high-risk patients. This study describes the 
immediate and medium-term outcomes of stent implantation in neonates and infants with duct-dependent 
pulmonary circulation. 
Methods: This was a descriptive and prospective study including different cyanotic congenital heart diseases 
treated between 2014 and 2015. 
Results: Fourteen patients with a mean age of 46 days, and mean weight of 4.5 kg were assessed, and 
pulmonary artresia with interventricular communication was the most treated condition. The femoral 
artery approach was used in 70% of procedures;  carotid approach was used in the remaining cases. Stents 
of 3.5 x 12 mm were used in most cases, and implant success was achieved in 78% of interventions (11/14). 
The failed cases were referred to surgery – one of them was an emergency, which resulted in death. Ductal 
spasm occurred in < 48 hours in three patients who required mBT, with favorable outcome. Complications 
after discharge and within the first 30 days included stent thrombosis (2/11), one of which was controlled 
with redilation, another progressed to death, and one sudden death (1/11). The overall mortality was 
21.4% (3/14). A patent ductus arteriosus in the first 6 months was present in five cases, which underwent 
palliative surgery. 
Conclusions: The initial experience of ductal stenting showed favorable immediate outcomes, but in the medium 
term, little more than a third of the cases maintained a patent ductus arteriosus within 6 months.
© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Published by Elsevier Editora Ltda. 
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 
 
Resultados imediatos e de médio prazo da intervenção com stent ductal em 
recém-nascidos e lactentes
R E S U M O
Introdução: O implante de stents para manter o ducto arterial patente na cardiopatia congênita cianótica é 
uma alternativa à cirurgia de Blalock-Taussig modificada (BTm) em pacientes de alto risco. Descrevemos os 
resultados imediatos e de médio prazo do implante de stent em neonatos e lactentes com circulação pulmonar 
ducto-dependente. 
Métodos: Trata-se de estudo descritivo e prospectivo, que incluiu diferentes cardiopatias congênitas cianóticas 
tratadas entre 2014 e 2015. 
Resultados: Avaliamos 14 pacientes, com média de idade de 46 dias e pesando 4,5 kg, sendo a atresia pulmonar 
associada à comunicação interventricular a cardiopatia mais tratada. A abordagem pela artéria femoral ocorreu 
em 70% dos procedimentos e, nos demais, por via carotídea. Stents de 3,5 × 12 mm foram usados na maioria 
dos casos, e o sucesso do implante foi obtido em 78% das intervenções (11/14). Os casos de insucesso foram 
encaminhados para cirurgia − uma delas em situação de urgência, que resultou em óbito. Ocorreu espasmo ductal 
< 48 horas em três pacientes que necessitaram de BTm, com evolução favorável. Complicações após a alta e nos 
primeiros 30 dias incluíram trombose de stent (2/11), uma delas controlada com redilatação e outra que evoluiu 
para óbito, e uma morte súbita (1/11). A mortalidade total foi de 21,4% (3/14). A patência do ducto arterial nos 
primeiros 6 meses foi obtida em 5 casos que foram submetidos à cirurgia paliativa. 
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Introduction
Congenital heart disease patients with duct-dependent pulmo-
nary circulation require urgent treatment in the first days of life to 
ensure pulmonary blood flow before the duct closes. Prostaglandin 
E1 infusion is generally effective in maintaining the patency of the 
ductus arteriosus.1 Pulmonary atresia with intact ventricular sep-
tum, extreme tetralogy of Fallot, tricuspid atresia with pulmonary 
atresia, and critical pulmonary stenosis, among others, are condi-
tions dependent on continuing patency of the ductus arteriosus.
Traditionally, the first treatment option is the modified Blalock-
-Taussig (mBT) surgery; however, it can be limited by the lack of ex-
perience of the service or due to patient-related factors such as very 
severe disease or very low birth weight.2 The mBT surgery consists 
of a systemic pulmonary shunt, and is mostly performed as a pallia-
tive surgery to improve pulmonary blood flow prior to the definitive 
surgery. Although this surgery has been used for over 50 years, there 
is still high morbidity and mortality, particularly among newborns 
and in early infancy.3,4
In 1992, Gibbs et al. first described maintenance of ductal pa-
tency with stenting during cardiac catheterization.5 Since then, 
stenting has achieved wide acceptance as a reliable alternative, 
considered to be as safe and effective as mBT surgery in high-risk 
patients. Moreover, it has other potential advantages such as re-
ducing the number of palliative surgeries and optimize the time 
for definitive surgical repair.6,7
This study presents an early experience with this technique in 
newborns and infants with cyanotic heart disease and duct-depen-
dent pulmonary circulation undergoing ductal stenting as an alter-
native to conventional surgery. The immediate and medium-term 
outcomes and complications are presented.
Methods
Newborns and infants with duct-dependent congenital heart 
disease underwent ductal stenting from January 2014 to March 
2015, at the Instituto Nacional de Salud del Niño de Lima and at 
the National Hospital Dos de Mayo, in Lima, Peru, with prior in-
formed consent. 
Patients were selected by a medical team, and presented with 
echocardiography and, in most cases, CT angiography (Fig. 1). These 
patients were considered to be at high surgical risk, so they were 
referred to percutaneous intervention. 
Under general anesthesia and endotracheal intubation, the appro-
ach was made considering the most favorable access to the duct in 
accordance with its origin in the aortic arch or descending aorta8 (pre-
viously defined in CT angiography, or if not available, by echocardio-
gram). An 5 F sheath was placed using Seldinger technique in the 
femoral access (whether venous or arterial), or through direct dissec-
tion and puncture when in the carotid artery.
All patients were started on prostaglandin E1 infusion, and the 
dose was gradually reduced or suspended when the duct was appro-
ached, and the guide passed through the narrowest area; this 
Conclusões: A experiência inicial de implante de stent ductal mostrou resultados imediatos favoráveis, e, em 
médio prazo, mais de um terço dos pacientes com circulação pulmonar ducto-dependente manteve seus 
canais patentes.
© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Publicado por Elsevier Editora Ltda. 
Este é um artigo Open Access sob a licença de CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Computed tomography angiography of heart and great vessels in a case of 
pulmonary atresia and interventricular communication.
Figure 2. Control X-ray on the fifth day after ductal stent implantation in a case of 
pulmonary atresia and interventricular communication.
allowed for a clear definition of the constriction, minimizing the risk 
of hypoxic crisis.
Angiography was performed with pigtail catheter or, on other oc-
casions, through a guide catheter near the duct.
A catheter guide was used to address the duct and then to cross the 
narrowest area with a 0.014” angioplasty guide. Stents 3.0/12 mm, 
3.5/16 mm, or 4.0/12 mm were used in this study.
At the beginning of the procedure, 100 U/kg intravenous heparin 
was given; at the end, antiplatelet therapy was started with acetyl-
salicylic acid 5mg/kg and clopidogrel 2 mg/kg.
The implantation was considered successful when oxygen sa-
turation above 75% was achieved, along with complete patency of 
the duct with adequate f low to the pulmonary branches. The 
follow-up was clinical: a 24-hour control echocardiogram was 
performed after the procedure, and radiological controls were 
performed as needed (Fig. 2).
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Results
Fourteen patients with several cyanotic congenital heart diseases 
and a mean age of 46 days (10 to 68 days) and mean weight of 4.5 kg 
(2.5 to 5.9 kg) were studied. The heart diseases were type I-A tricus-
pid atresia (3/14), pulmonary atresia and interventricular communi-
cation (7/14), Ebstein’s anomaly and pulmonary atresia (2/14), and 
single ventricle and pulmonary atresia (2/14) (Table 1).
The arterial or venous femoral artery approach was used in 71% 
of cases (Figs. 3 and 4); and through the carotid artery in the remai-
ning cases, with the assistance of a cardiovascular surgeon (Fig. 5).
Anterograde access through the femoral vein (5/14), retrograde 
access through the femoral artery (5/14), and through the carotid 
artery (4/14) were used. Regarding the type of duct, we found the 
elongated type, originating in the descending aorta; the curved 
type, originating in the distal aortic arch; or the tortuous type, origi-
nating in the vertical aortic arch.
The mean procedure time and mean fluoroscopy time were 95 ± 
18 minutes and 36 ± 12 minutes, respectively. Stents 3.5/12 mm were 
used in 75% of cases and 3.0/16 mm or 4.0/12 mm in the remaining 
cases; depending on the length of the duct, up to two stents were 
placed, as needed.
Table 1
Clinical data and complications.
Case Age 
(days)
Weight 
(kg)
Diagnosis Stent 
(mm)
Outcome  
< 48 hour
Progress and/or 
reintervention
1 21 2.8 Tricuspid atresia +  
pulmonary atresia 
3.0 × 12 Successful Ductal spasm. mBT surgery
2 30 2.7 Single ventricle +  
pulmonary stenosis 
- Failure mBT surgery
3 52 3.2 Pulmonary atresia + IVC 3.5 × 12 Successful Ductal spasm. mBT surgery
4 68 5.0 Pulmonary atresia + IVC 3.5 × 12 Successful Stent thrombosis, death
5 20 3.8 Severe Ebstein’s anomaly + 
pulmonary atresia
3.5 × 12 Successful Sudden death
6 30 3.7 Pulmonary atresia + IVC 3.0 × 12
3.5 × 16
Successful Stent thrombosis and 
redilation
7 40 5.9 Pulmonary atresia + IVC 3.5 × 18 Successful Favorable 
8 30 3.1 Severe Ebstein’s anomaly + 
pulmonary atresia
3.5 × 12 Successful Ductal spasm. mBT surgery
9 31 3.2 Single ventricle +  
pulmonary atresia 
3.5 × 12
3.5 × 16
Successful Favorable
10 10 3.9 Tricuspid atresia. +  
pulmonary atresia
3.5 × 12 Successful Favorable
11 21 3.2 Tricuspid atresia +  
pulmonary atresia
- Failure mBT surgery
12 14 3.2 Extreme Fallot Tetralogy 3.5 × 12
4.0 × 16
Failure Guide stuck to the stent, 
emergency surgery
Death 
13 30 2.5 Pulmonary atresia + IVC 4.0 × 12
4.0 × 12
Successful Favorable
14 42 4.1 Pulmonary atresia + IVC 4.0 × 12
4.0 × 16
Successful Favorable
mBT: modified Blalock-Taussig surgery; IVC: interventricular communication.
Figure 3. Femoral venous approach (Seldinger technique). (A) Ventriculography in a case of single ventricle and pulmonary atresia. (B) Aortogram and selective angiography of 
the ductus arteriosus (age: 29 days; weight 3,700 g).
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The implant success rate was 79% (11/14). In two cases, stenting 
was not possible, and mBT surgery was required. In the third case, 
there was a major complication during the procedure, which requi-
red emergency surgery and led to a fatal outcome. Regarding other 
complications associated with the procedure, three patients who 
required mBT surgery, presented ductal spasm before 48 hours, with 
favorable outcome.
Extra-hospital complications in the first 30 days included stent 
thrombosis, with one improving after stent redilation, and the other 
evolving to death; there was also one sudden death. The overall 
mortality was 21.4% (3/14).
The medium-term evolution was favorable with presence of pa-
tent duct for over 4 to 6 months in five patients, who underwent 
palliative surgery. 
Discussion
In this institution, mBT palliative surgery has been routinely per-
formed for over 25 years; however, as in other centers, it still has 
considerable morbidity and mortality rates due to possible compli-
cations such as pulmonary artery distortion and stenosis, pleural 
effusion, chylothorax, phrenic and vagus nerve paralysis, and diffe-
rential branch pulmonary artery growth, as well as the patients cli-
nical profile (severe hypoxemia, low birth weight, prematurity, 
among others).9
Conversely, there are several limitations of infrastructure, and 
insufficient human resources to meet the growing demand for car-
diac surgeries in increasingly complex patients. Under these cir-
cumstances, the development of percutaneous ductal stent 
techniques enables treating patients with duct-dependent cyanotic 
heart disease, establishing itself as an alternative palliative approa-
ch.
Ductal stenting and surgical shunts are the most common proce-
dures in patients who have no other effective pulmonary arterial 
source other than the ductus arteriosus. The patency of the duct 
through the stent is as effective as mBT surgery in promoting the 
overall growth of the pulmonary artery in duct-dependent congeni-
tal heart diseases.10,11
In the present study, the immediate outcomes were favorable in 
most cases, although duct anatomy was not optimal (70% were large 
and tortuous ducts). When comparing this experience with other se-
Figure 4. Femoral arterial approach (Seldinger technique). Aortogram in a case of pulmonary atresia and interventricular communication (age: 32 days; weight: 3,950 g).
Figure 5. Carotid approach through dissection. (A) Dissection and direct puncture in the carotid artery in a case of pulmonary atresia and interventricular communication. (B) 
Duct access through 5 F sheath (age: 25 days; weight: 3,850 g).
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ries,12,13 similarities in the clinical characteristics of patients regarding 
diagnosis, age, and weight could be observed; the implantation success 
rate was 79%, very close to the reported average rates (80 to 100%).
Regarding complications related to the procedure, they are un-
common, including major complications such as stent migration (in 
the present study, one case, 9%) and acute stent thrombosis (two ca-
ses, 18%); similar to other series.14 In addition, congestive heart failu-
re was observed in four patients, related to excessive pulmonary 
blood flow, which improved with diuretics and water restriction; 
and one of the patients also had moderate pericardial effusion. The-
se complications are not usually observed. In the present study, im-
mediate mortality was 7.1%, as a result of emergency surgery due to 
guide wire entrapment behind one of the stents, with subsequent 
migration of the device into the left pulmonary branch.
However, the patency of the stent in our group in the medium 
term was different than that reported in other studies.15 Just over a 
third of cases showed patent stents, condition associated with the 
use of 3.0 and 3.5 mm stents, and the incomplete coverage of the 
duct. As the procedure was consolidated, larger caliber (4 mm) 
stents were implanted, multiple stents were used, covering thus all 
the duct extension, increasing the chances of maintaining stent pa-
tency. Moreover, the last cases were approached by direct dissection 
and carotid artery puncture, allowing the use of larger stents and 
facilitating the access to the duct.
The literature indicates that stenosis usually develops over a pe-
riod of 6 months to 1 year of stent implantation.16 Therefore, surgical 
interventions, such as Glenn surgery for univentricular heart or total 
correction in biventricular hearts, should be performed as soon as 
possible. However, it is possible to successfully dilate the stent in 
some of these patients to gain more time before surgery. In this stu-
dy, one patient required stent redilation and placement of a larger-
-caliber stent to increase the flow to the pulmonary branches and 
improve oxygen saturation.
In recent years, stent implantation in the ductus arteriosus gai-
ned wide acceptance as a reliable alternative to the systemic-pulmo-
nary surgery in patients with duct-dependent congenital cyanotic 
heart disease. This option is considered safer and more effective 
than palliative surgery in high-risk patients, as it is possible to adapt 
the stent to the patient size and pulmonary anatomy.17 However, the 
ability of ductus stenting to promote a significant growth of the pul-
monary artery branches has not been specifically evaluated. Theo-
retically, if the stent is fitted to the size and angulation of the 
pulmonary artery, an even distribution of pulmonary blood flow 
could take place, thereby promoting uniform vascular develop-
ment.18 This hypothesis is currently being evaluated, but with limi-
ted data so far.
Conclusions
Ductal stenting had favorable immediate outcomes; however, in 
the medium term, ductal patency for over 6 months was maintained 
in less than 50% of cases.
The optimal outcome requires the duct to not be too big or too 
tortuous, a condition that was present in most of the present pa-
tients. The authors believe that in the future, with better-selected 
cases (more favorable ductal anatomy) and the use of larger-caliber 
stents (4 to 4.5 mm), the immediate success rate will improve, and a 
medium term patency will be achieved, optimizing the results for 
the benefit of patients.
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